IRCT20210620051631N1招募中3 期
Evaluation of the oral Nicorandil effect on reducing the contrast-induced nephropathy incidence in cardiac catheterization patients: a randomized controlled clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 344
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Based on the risk score,Have a moderate risk or at least two risk factors for contrast nephropathy.
- •EF less than 40
- •Diabetes mellitus.
- •Blood pressure above 140/90 mm Hg,
- •Renal failure (GFR) less than 60
- •No pregnancy
- •(basal serum creatinine above 1.5 mg / dl)
- •Minimum age 18
排除标准
- •Pulmonary edema
- •Cardiogenic shock
- •Multiple myeloma
- •Acute renal failure
- •ESRD(GFR<15 mg/dl)
- •Allergy to media contrast
- •Nicorandil allergy
- •Facing media contrast in the last 7 days
- •NAC and metformin and dopamine and sodium bicarbonate and mannitol and phenol dopam in the last 48 hours
研究者
相似试验
招募中
2 期
The effect of nicorandil on arrhythmiaIRCT20181104041555N1Zahedan University of Medical Sciences100
招募中
3 期
Effect of Nicorandil on contrast-induced nephropathycontrast-induced nephropathy.Nephropathy induced by other drugs, medicaments and biological substancesICD 10- N1IRCT20230110057096N1Rasht University of Medical Sciences264
招募中
3 期
Oral nicorandil in PPCIAcute myocardial infarctionIRCT20140512017666N1Tabriz University of Medical Sciences240
已完成
2 期
Efficacy of nicorandil in acute coronary syndromeAcute coronary syndrome.Ischaemic heart disease120_125IRCT201202189067N1Vice chancellor for research, Kermanshah University of Medical Siences and Health Services252
招募中
4 期
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery DiseaseNo-Reflow PhenomenonPercutaneous Coronary InterventionCoronary Artery DiseaseNCT05427786Korea University Anam Hospital458